
ML-210
CAS No. 1360705-96-9
ML-210( ML 210 | ML210 )
Catalog No. M11484 CAS No. 1360705-96-9
A small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | Get Quote |
![]() ![]() |
5MG | 71 | Get Quote |
![]() ![]() |
10MG | 129 | Get Quote |
![]() ![]() |
25MG | 233 | Get Quote |
![]() ![]() |
50MG | 393 | Get Quote |
![]() ![]() |
100MG | 566 | Get Quote |
![]() ![]() |
200MG | 803 | Get Quote |
![]() ![]() |
500MG | 1188 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameML-210
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
-
DescriptionA small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM, displays 23-fold sensitivity over BJeH-LT (isogenic to BJeLR without HRAS G12V) cell lines; a useful tool for identifying oncogene-specific pathways and targets in cancer cells.
-
In Vitro——
-
In Vivo——
-
SynonymsML 210 | ML210
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1360705-96-9
-
Formula Weight475.32
-
Molecular FormulaC22H20Cl2N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (52.60 mM)
-
SMILESO=C(N1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=C(Cl)C=C3)CC1)C4=NOC(C)=C4[N+]([O-])=O
-
Chemical Name(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. We?wer M, et al. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1822-6.
molnova catalog



related products
-
KRAS inhibitor-9
KRAS inhibitor-9 is a potent KRAS inhibitor with Kd of 92 μM that blocks the formation of GTP-KRAS and downstream activation of KRAS.?
-
Lanperisone
Lanperisone (NK 433) is a centrally acting muscle relaxant that selectively kills of K-ras mutant cancer cells in a cell cycle-independent fashion.
-
ARS-1323
ARS1323 is a racemic mixture of ARS-1620/R-atropisomer, ARS-1620 is a potent, specific and covalent KRAS G12C inhibitor.